Application of platform process development approaches to the manufacturing of Mabcalin™ bispecifics-Reference-Cited by-同舟云学术

Application of platform process development approaches to the manufacturing of Mabcalin™ bispecifics

Published:2023-11 Issue: Volume:377 Page:13-22
ISSN:0168-1656
Container-title:Journal of Biotechnology
language:en
Short-container-title:Journal of Biotechnology

Author:

Wachter Stefanie,Angevin Thibaut,Bubna Niket^ORCID,Tan Adelene,Cichy Adam,Brown David^ORCID,Wolfe Leslie S.,Sappington Ryan^ORCID,Lilla Edward,Berry Luke,Grismer Dane^ORCID,Orth Christian,Blanusa Milan^ORCID,Mostafa Sigma,Kaufmann Hitto,Felderer Karin

Publisher

Elsevier BV

Subject

Applied Microbiology and Biotechnology,General Medicine,Biotechnology,Bioengineering

Reference39 articles.

1. Lipocalins;Åkerström,2006

2. An integrated approach to aggregate control for therapeutic bispecific antibodies using an improved three column mab platform-like purification process;Andrade;Biotechnol. Prog.,2019

3. Clinical experiences with anti-CD137 and anti-PD1 therapeutic antibodies;Ascierto;Semin Oncol.,2010

4. Bispecific T-cell engaging antibodies for cancer therapy;Baeuerle;Cancer Res,2009

5. Current trends and challenges in the downstream purification of bispecific antibodies;Chen;Antib. Ther.,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stepwise cell culture process intensification for high-productivity and cost-effective commercial manufacturing of a Mabcalin™ bispecifics;Biochemical Engineering Journal;2024-11

2. Holistic in silico developability assessment of novel classes of small proteins using publicly available sequence-based predictors;Journal of Computer-Aided Molecular Design;2024-08-20

3. Phage display technology and its impact in the discovery of novel protein-based drugs;Expert Opinion on Drug Discovery;2024-06-18

4. Holistic in silico developability assessment of novel classes of small proteins using publicly available sequence-based predictors;2023-11-11